Table 1.
Characteristics of the arrayed prostate cancer tumors and clinical data.
| Characteristics | Total | % |
|---|---|---|
| No. of cases | 187 | 100 |
| No. unique cases w/evaluable cores | 170 | 90.9 |
| No. of cores | 882 | 100 |
| No. of evaluable cores | 797 | 90.4 |
| Age (years) | 41–79 years old | |
| 41–49 | 6 | 3.5 |
| 50–59 | 44 | 25.9 |
| 60–69 | 76 | 44.8 |
| 70–79 | 39 | 22.9 |
| Unknown | 5 | 2.9 |
| Mean | 63.4 | |
| Pathologic stage | ||
| 2a | 4 | 2.4 |
| 2b | 2 | 1.2 |
| 2c | 47 | 28.3 |
| 3a | 109 | 65.7 |
| 3b | 4 | 2.4 |
| Unknown | 4 | 2.4 |
| PSA (pre-radical prostatectomy) | 165 cases | |
| Unknown | 5 cases | |
| Range | 1–120 ng/mL | |
| Mean | 11.56 ng/mL | |
| PSA (post-radical prostatectomy) | 136 cases | |
| Unknown | 34 cases | |
| Range | 0–163 ng/mL | |
| Mean | 2.43 ng/mL | |
| Biochemical recurrence | ≥0.2 ng/mL (77 cases) |